Daniel Helbling
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Hani Oweira (11 shared papers)Arianeb Mehrabi (11 shared papers)Jan Schmidt (11 shared papers)Omar Abdel‐Rahman (11 shared papers)Anwar Giryes (11 shared papers)Othmar Schöb (10 shared papers)Ulf Petrausch (11 shared papers)Meinrad Mannhart (5 shared papers)
- Journals
- Cancers (3 papers)Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)Clinical Oncology (2 papers)European Spine Journal (2 papers)
- Partner nations
- SwitzerlandGermanyEgypt
In The Last Decade
Daniel Helbling
30 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Oncology 437
- Hepatology 82
- Pharmacology 130
- Hematology 66
- Pulmonary and Respiratory Medicine 162
Countries citing papers authored by Daniel Helbling
This map shows the geographic impact of Daniel Helbling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Helbling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Helbling more than expected).
Fields of papers citing papers by Daniel Helbling
This network shows the impact of papers produced by Daniel Helbling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Helbling. The network helps show where Daniel Helbling may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Helbling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 134 | |
| 2 | 2017 | 120 | |
| 3 | 2008 | 108 | |
| 4 | 2017 | 87 | |
| 5 | 2004 | 71 | |
| 6 | 2009 | 69 | |
| 7 | 2002 | 69 | |
| 8 | 2011 | 68 | |
| 9 | 2012 | 59 | |
| 10 | 2016 | 44 | |
| 11 | 2017 | 37 | |
| 12 | 2010 | 35 | |
| 13 | 2016 | 33 | |
| 14 | 2017 | 21 | |
| 15 | 2021 | 21 | |
| 16 | 1997 | 21 | |
| 17 | 2018 | 19 | |
| 18 | 2017 | 18 | |
| 19 | 2010 | 15 | |
| 20 | 2019 | 13 |
About Daniel Helbling
Daniel Helbling is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology and Pharmacology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Musculoskeletal pain and rehabilitation (3 papers), Gastric Cancer Management and Outcomes (3 papers), Ovarian cancer diagnosis and treatment (2 papers), Lung Cancer Research Studies (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Oncology (437 citations), Hepatology (82 citations), Pharmacology (130 citations), Hematology (66 citations) and Pulmonary and Respiratory Medicine (162 citations). Daniel Helbling has collaborated with scholars based in Switzerland, Germany and Egypt. Frequent co-authors include Hani Oweira, Arianeb Mehrabi, Jan Schmidt, Omar Abdel‐Rahman, Anwar Giryes, Othmar Schöb, Ulf Petrausch, Meinrad Mannhart, Haiko Sprott and Anne F. Mannion. Their work appears in journals such as Cancers, Annals of Oncology, Journal of Clinical Oncology, Clinical Oncology and European Spine Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.